妊娠期血小板减少症
Thrombocytopenia in Pregnancy.
作者信息
Ciobanu Anca Marina, Colibaba Simona, Cimpoca Brandusa, Peltecu Gheorghe, Panaitescu Anca Maria
机构信息
Filantropia Clinical Hospital, Bucharest, Romania.
出版信息
Maedica (Bucur). 2016 Mar;11(1):55-60.
Abstract
Thrombocytopenia, defined as blood platelet count below 150,000/ìL is the second leading cause of blood disorders in pregnancy after anemia. Gestational thrombocytopenia explains 70-80% of all cases of thrombocytopenia in pregnancy. Hypertensive disorders account for approximately 20% and immune thrombocytopenic purpura for about 3-4%. Other etiologies are considered rare in pregnancy. The aim of this study is to review the specific causes of thrombocytopenia in pregnancy, their obstetrical implications and management.
摘要
血小板减少症定义为血小板计数低于150,000/μL，是孕期仅次于贫血的第二大血液系统疾病病因。妊娠期血小板减少症占孕期所有血小板减少症病例的70 - 80%。高血压疾病约占20%，免疫性血小板减少性紫癜约占3 - 4%。其他病因在孕期被认为较为罕见。本研究的目的是回顾孕期血小板减少症的具体病因、其产科影响及管理。
相似文献
1
Thrombocytopenia in Pregnancy.妊娠期血小板减少症
Maedica (Bucur). 2016 Mar;11(1):55-60.
2
[Etiology and clinical characteristics of pregnancy-emerged thrombocytopenia].[妊娠合并血小板减少症的病因及临床特征]
Zhonghua Fu Chan Ke Za Zhi. 2011 Nov;46(11):834-9.
3
Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.一名已知患有特发性（免疫性）血小板减少性紫癜的患者发生产后血栓性血小板减少性紫癜：病例报告及文献综述
J Med Case Rep. 2018 Jun 1;12(1):147. doi: 10.1186/s13256-018-1692-1.
4
Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura.对疑似免疫性血小板减少性紫癜孕妇后代血小板减少风险的评估。
N Engl J Med. 1990 Jul 26;323(4):229-35. doi: 10.1056/NEJM199007263230404.
5
5 Years' Experience of a Tertiary Center with Thrombocytopenic Pregnancies: Gestational Thrombocytopenia, Idiopathic Thrombocytopenic Purpura and Hypertensive Disorders of Pregnancy.一家三级医疗中心处理血小板减少性妊娠（包括妊娠期血小板减少症、特发性血小板减少性紫癜和妊娠高血压疾病）的5年经验
Geburtshilfe Frauenheilkd. 2020 Jan;80(1):76-83. doi: 10.1055/a-0865-4442. Epub 2019 Jul 24.
6
Immune thrombocytopenic purpura in pregnancy.妊娠期免疫性血小板减少性紫癜
Curr Opin Hematol. 2007 Sep;14(5):574-80. doi: 10.1097/MOH.0b013e3282bf6dc2.
7
[Percutaneous umbilical blood sampling in pregnant women with thrombocytopenia. Apropos of 35 cases].血小板减少症孕妇的经皮脐血采样。附35例报告
J Gynecol Obstet Biol Reprod (Paris). 2000 Apr;29(2):176-84.
8
The presentation and management of platelet disorders in pregnancy.妊娠期血小板疾病的表现与处理。
Eur J Haematol. 2018 Jun;100(6):560-566. doi: 10.1111/ejh.13049. Epub 2018 Apr 6.
9
ITP in pregnancy and the newborn: introduction.妊娠及新生儿特发性血小板减少性紫癜：引言
Blut. 1989 Jul;59(1):124-7. doi: 10.1007/BF00320263.
10
[Managing a pregnant woman with a low platelet count].[管理血小板计数低的孕妇]
Rev Med Interne. 2008 Oct;29(10):808-14. doi: 10.1016/j.revmed.2007.11.004. Epub 2008 Jan 3.
引用本文的文献
1
Use and Effects of Eltrombopag in Pregnant Woman With Difficult-to-Treat Idiopathic Thrombocytopenic Purpura (ITP).艾曲泊帕在难治性特发性血小板减少性紫癜（ITP）孕妇中的应用及效果
Case Rep Hematol. 2025 Jul 24;2025:2509169. doi: 10.1155/crh/2509169. eCollection 2025.
2
Pregnancy and postpartum dynamics revealed by millions of lab tests.数百万次实验室检测揭示的妊娠及产后动态。
Sci Adv. 2025 Mar 28;11(13):eadr7922. doi: 10.1126/sciadv.adr7922. Epub 2025 Mar 26.
3
ITP in pregnancy: diagnostics and therapeutics in 2024.妊娠特发性血小板减少性紫癜：2024年的诊断与治疗
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):685-691. doi: 10.1182/hematology.2024000595.
4
Navigating Primary Immune Thrombocytopenia During Pregnancy With Management Strategies and Considerations: A Comprehensive Review.妊娠期间原发性免疫性血小板减少症的管理策略与考量：一项综述
Cureus. 2024 Aug 21;16(8):e67449. doi: 10.7759/cureus.67449. eCollection 2024 Aug.
5
Navigating Primary Immune Thrombocytopenia During Pregnancy: Management Strategies and Considerations: A Comprehensive Review.孕期原发性免疫性血小板减少症的应对：管理策略与注意事项：全面综述
Cureus. 2024 Aug 20;16(8):e67284. doi: 10.7759/cureus.67284. eCollection 2024 Aug.
6
Prevalence of Thrombocytopenia in Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis.新冠病毒肺炎孕妇血小板减少症的患病率：一项系统评价和荟萃分析
J Clin Med. 2024 Aug 23;13(17):4980. doi: 10.3390/jcm13174980.
7
Genetic Association between Inflammatory-Related Polymorphism in , , , and Idiopathic Recurrent Implantation Failure.炎症相关多态性与特发性复发性植入失败的遗传关联： 、 、 、 。
Genes (Basel). 2023 Aug 5;14(8):1588. doi: 10.3390/genes14081588.
8
Dengue in Pregnancy: A Southeast Asian Perspective.妊娠期间的登革热：东南亚视角
Trop Med Infect Dis. 2023 Jan 27;8(2):86. doi: 10.3390/tropicalmed8020086.
9
Recurrent Gestational Thrombocytopenia Affecting Four Consecutive Pregnancies: A Case Report.复发性妊娠期血小板减少症累及连续四次妊娠：一例报告
Cureus. 2023 Jan 20;15(1):e34005. doi: 10.7759/cureus.34005. eCollection 2023 Jan.
10
Thrombocytopaenia and COVID-19 infection during pregnancy increases the risk of preeclampsia: a multicentre study.妊娠期血小板减少症和 COVID-19 感染增加子痫前期的风险：一项多中心研究。
Reprod Biomed Online. 2023 Feb;46(2):371-378. doi: 10.1016/j.rbmo.2022.11.001. Epub 2022 Nov 6.
本文引用的文献
1
Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis.在逐步增加依库珠单抗剂量以控制突破性溶血后阵发性睡眠性血红蛋白尿（PNH）患者获得成功妊娠结局。
Leuk Res Rep. 2015 May 16;4(1):36-8. doi: 10.1016/j.lrr.2015.05.001. eCollection 2015.
2
How I treat thrombocytopenia in pregnancy.我如何治疗妊娠期血小板减少症。
Blood. 2013 Jan 3;121(1):38-47. doi: 10.1182/blood-2012-08-448944. Epub 2012 Nov 13.
3
p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.p53 Arg72Pro 多态性、HPV 状态与宫颈癌的发生、进展和发展：系统评价和荟萃分析。
Clin Cancer Res. 2012 Dec 1;18(23):6407-15. doi: 10.1158/1078-0432.CCR-12-1983. Epub 2012 Oct 12.
4
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.血栓性血小板减少性紫癜及其他血栓性微血管病的诊断与管理指南
Br J Haematol. 2012 Aug;158(3):323-35. doi: 10.1111/j.1365-2141.2012.09167.x. Epub 2012 May 25.
5
Diagnosis and management of maternal thrombocytopenia in pregnancy.妊娠合并血小板减少症的诊断与处理。
Br J Haematol. 2012 Jul;158(1):3-15. doi: 10.1111/j.1365-2141.2012.09135.x. Epub 2012 May 3.
6
Genital human papillomavirus infections: current and prospective therapies.生殖器人乳头瘤病毒感染：当前和未来的治疗方法。
J Gen Virol. 2012 Apr;93(Pt 4):681-691. doi: 10.1099/vir.0.039677-0. Epub 2012 Feb 8.
7
Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?p53基因第72位密码子多态性对宫颈癌发生发展有影响，这有生物学合理性吗？
Acta Med Port. 2011 Jan-Feb;24(1):127-34. Epub 2011 Feb 28.
8
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.美国血液学会 2011 年免疫性血小板减少症循证实践指南。
Blood. 2011 Apr 21;117(16):4190-207. doi: 10.1182/blood-2010-08-302984. Epub 2011 Feb 16.
9
Human papillomavirus regulation of SR proteins.人乳头瘤病毒对 SR 蛋白的调控。
Biochem Soc Trans. 2010 Aug;38(4):1116-21. doi: 10.1042/BST0381116.
10
Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.免疫调节剂和生物制剂在妊娠期和哺乳期治疗炎症性肠病的安全性。
Inflamm Bowel Dis. 2010 May;16(5):881-95. doi: 10.1002/ibd.21154.
Zotero 插件